Medi Caps Ltd (MEDICAPS) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Roopa Industries

ANG Lifesciences

Sandu Pharma.

Murae Organisor

Guj. Terce Labs.

Medi Caps

Venmax Drugs

Welcure Drugs

Lasa Supergeneri

Chandra Bhagat

Medicamen Organ.

Why is Medi Caps Ltd ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.00
The company has been able to generate a Return on Equity (avg) of 2.03% signifying low profitability per unit of shareholders funds

Flat results in Mar 26

NET SALES(Latest six months) At Rs 7.75 cr has Grown at -29.48%
DEBTORS TURNOVER RATIO(HY) Lowest at 1.79 times
OPERATING PROFIT TO NET SALES (Q) Lowest at 0.00%

Risky - Negative EBITDA

The company has recorded a negative EBITDA of Rs. -9.39 cr
Over the past year, while the stock has generated a return of -31.21%, its profits have fallen by -246%
The stock is trading risky as compared to its average historical valuations

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -31.21% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Medi Caps for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Medi Caps

-31.21%

-0.59

52.55%

Sensex

-7.92%

-0.61

13.09%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-26.66%

EBIT Growth (5y)

-201.01%

EBIT to Interest (avg)

-1.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.21

Sales to Capital Employed (avg)

0.33

Tax Ratio

0.66%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

0.32%

ROE (avg)

2.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.33

EV to EBIT

-1.11

EV to EBITDA

-1.32

EV to Capital Employed

0.14

EV to Sales

1.00

PEG Ratio

Dividend Yield

ROCE (Latest)

-12.78%

ROE (Latest)

-2.72%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

PAT(Q)

At Rs 3.04 cr has Grown at 378.9% (vs previous 4Q average

EPS(Q)

Highest at Rs 2.44

-9What is not working for the Company

NET SALES(Latest six months)

At Rs 7.75 cr has Grown at -29.48%

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.79 times

OPERATING PROFIT TO NET SALES (Q)

Lowest at 0.00%

PBT LESS OI(Q)

At Rs -2.56 cr has Fallen at -9.4% (vs previous 4Q average

NON-OPERATING INCOME(Q)

is 184.49 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Medi Caps

Profit After Tax (PAT) - Quarterly

At Rs 3.04 cr has Grown at 378.9% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs -1.09 Cr

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly

Highest at Rs 3.04 cr.

in the last five quarters

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly

Highest at Rs 2.44

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Medi Caps

Net Sales - Latest six months

At Rs 7.75 cr has Grown at -29.48%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit Margin - Quarterly

Lowest at 0.00%

in the last five quarters

MOJO Watch

Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs -2.56 cr has Fallen at -9.4% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs -2.34 Cr

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Non Operating Income - Quarterly

is 184.49 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Debtors Turnover Ratio- Half Yearly

Lowest at 1.79 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly

Highest at Rs 5.59 cr

in the last five quarters

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating Income